Amkay Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 10-12-2024
- Paid Up Capital ₹ 2.00 M
as on 10-12-2024
- Company Age 38 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 4.57 M
as on 10-12-2024
- Satisfied Charges ₹ 1.80 M
as on 10-12-2024
About Amkay Laboratories
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.57 M. The company has closed loans amounting to ₹1.80 M, as per Ministry of Corporate Affairs (MCA) records.
Mayank Rastogi and Madhury Rastogi serve as directors at the Company.
- CIN/LLPIN
U24241UP1986PTC008315
- Company No.
008315
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 1986
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Meerut, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Amkay Laboratories Private Limited offer?
Amkay Laboratories Private Limited offers a wide range of products and services, including Healthcare Products & Aids, Adult Diapers.
Who are the key members and board of directors at Amkay Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayank Rastogi  | Director | 01-Apr-2001 | Current |
| Madhury Rastogi | Director | 24-Oct-1986 | Current |
Financial Performance of Amkay Laboratories.
Amkay Laboratories Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Amkay Laboratories?
In 2017, Amkay Laboratories had a promoter holding of 97.55% and a public holding of 2.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Aug 2017 | ₹1.50 M | Open |
Central Bank Of India Creation Date: 22 Sep 1997 | ₹1.00 M | Open |
State Bank Of India Creation Date: 22 Feb 1990 | ₹1.07 M | Open |
How Many Employees Work at Amkay Laboratories?
Amkay Laboratories has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amkay Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amkay Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
